SP
Highly rated in
33
conditions
Highly rated in
33
conditions
Check Dr. Scott R. Plotkin's experience treating your condition:
About Dr. Scott R. Plotkin

Scott Plotkin is a Neurologist in Boston, Massachusetts. Plotkin has been practicing medicine for over 24 years and is highly rated in 33 conditions, according to our data. His top areas of expertise are Neurofibromatosis, Schwannomatosis, Neurofibromatosis Type 2, and Neurofibromatosis Type 1. He is licensed to treat patients in Massachusetts. Plotkin is currently accepting new patients.

His clinical research consists of co-authoring 165 peer reviewed articles and participating in 17 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Scott R. Plotkin it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Scott R. Plotkin accepts the following insurance:

  •  Ambetter
  •  Anthem

Call to see if your plan is accepted.
Locations
55 Fruit St, Boston, MA 02114
Background & Education
Graduate Institution
Tulane University School Of Medicine, 1998
Specialties
Neurology
Licenses
Psychiatry & Neurology in MA
Hospital Affiliations
Brigham And Womens Hospital
Massachusetts General Hospital
MassGeneral Hospital For Children
Massachusetts Eye And Ear
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


16 Clinical Trials

Prospective, Randomized, Placebo-Controlled Phase II Trial of Aspirin for Vestibular Schwannomas
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2 (INTUITT-NF2)
A Phase 1/2 Study of Selinexor in Combination With Standard of Care (SoC) Therapy for Newly Diagnosed or Recurrent Glioblastoma
Exploration and Estimation of Intratumoral Concentration and Activity of Lapatinib in Vivo in Vestibular Schwannomas
Pilot Study of Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma
A Phase 2 Study Evaluating the Efficacy and Safety of Selinexor (KPT-330) in Patients With Recurrent Gliomas
A Phase II Study of Binimetinib in Children and Adults With NF1 Associated Plexiform Neurofibromas (PNOC010)
Pilot Study of Ranibizumab (Lucentis) for Neurofibromas Associated With Neurofibromatosis 1
A Phase II Study of Cabozantinib (XL184) for Plexiform Neurofibromas in Subjects With Neurofibromatosis Type 1 in Children and Adults
Pilot Study of Topical Imiquimod 5% Cream for Treatment of Cutaneous Neurofibromas in Adults With Neurofibromatosis 1
Resiliency Training for Adolescent Neurofibromatosis Patients Via Videoconferencing With Skype
View 12 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors